ATE258598T1 - Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht - Google Patents

Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht

Info

Publication number
ATE258598T1
ATE258598T1 AT98943346T AT98943346T ATE258598T1 AT E258598 T1 ATE258598 T1 AT E258598T1 AT 98943346 T AT98943346 T AT 98943346T AT 98943346 T AT98943346 T AT 98943346T AT E258598 T1 ATE258598 T1 AT E258598T1
Authority
AT
Austria
Prior art keywords
molecular weight
low molecular
protein refolding
refolding method
zwitterionic agents
Prior art date
Application number
AT98943346T
Other languages
English (en)
Inventor
Steven M Vicik
Original Assignee
Inst Genetics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc
Application granted granted Critical
Publication of ATE258598T1 publication Critical patent/ATE258598T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98943346T 1997-10-08 1998-08-24 Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht ATE258598T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/946,839 US20020052026A1 (en) 1997-10-08 1997-10-08 Methods of refolding proteins
PCT/US1998/017499 WO1999018196A1 (en) 1997-10-08 1998-08-24 Methods of refolding proteins by use of zwitterionic low molecular weight agents

Publications (1)

Publication Number Publication Date
ATE258598T1 true ATE258598T1 (de) 2004-02-15

Family

ID=25485053

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98943346T ATE258598T1 (de) 1997-10-08 1998-08-24 Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht

Country Status (8)

Country Link
US (5) US20020052026A1 (de)
EP (1) EP1021528B1 (de)
JP (1) JP2001519149A (de)
AT (1) ATE258598T1 (de)
AU (1) AU757692B2 (de)
CA (1) CA2305559A1 (de)
DE (1) DE69821376D1 (de)
WO (1) WO1999018196A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19755960C1 (de) * 1997-12-16 1998-11-26 Hoechst Ag Verfahren zum Aufschluß von biologischem Material
FR2801219A1 (fr) * 2000-09-18 2001-05-25 Pf Medicament Procede de preparation de proteine recombinante renaturee en presence de detergent
EP1314739A1 (de) * 2001-11-22 2003-05-28 Bayer Ag Verfahren zur Renaturierung rekombinanter, Disulfid-enthaltender Proteine bei hohen Proteinkonzentrationen in Gegenwart von Aminen
DK1572127T4 (da) 2002-02-14 2014-11-24 Univ Leland Stanford Junior Enzymbehandling af fødevarer til cøliaki
US8143210B2 (en) 2002-02-14 2012-03-27 The Board Of Trustees Of The Leland Stanford Junior University Enzyme treatment of foodstuffs for celiac sprue
JP4401618B2 (ja) 2002-04-15 2010-01-20 キヤノン株式会社 記録装置、及び、バッファ管理方法
SI21273A (sl) * 2002-07-31 2004-02-29 LEK farmacevtska dru�ba d.d. Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina
ATE554392T1 (de) 2002-11-20 2012-05-15 Univ Leland Stanford Junior Diagnoseverfahren für sprue/zöliakie
EP1449848A1 (de) * 2003-02-20 2004-08-25 GBF German Research Centre for Biotechnology Verfahren zur Herstellung von Proteinen aus der Cystine-Knoten-Familie
US7579313B2 (en) 2003-11-18 2009-08-25 The Board Of Trustees Of The Leland Stanford Junior University Transglutaminase inhibitors and methods of use thereof
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604966D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
WO2008115411A1 (en) * 2007-03-16 2008-09-25 The Board Of Trustees Of The Leland Stanford Junior University Combination enzyme therapy for digestion of dietary gluten
WO2008115428A2 (en) * 2007-03-16 2008-09-25 The Board Of Trustees Of The Leland Stanford Junior University A scaleable manufacturing process for cysteine endoprotease b, isoform 2
CN101815944A (zh) * 2007-07-03 2010-08-25 安姆根有限公司 利用包含体干重的蛋白测量
EP3660032A1 (de) 2009-06-25 2020-06-03 Amgen, Inc Erfassungs-/reinigungsverfahren für in einem nichtsäugersystem exprimierte proteine
WO2012029148A1 (ja) 2010-09-01 2012-03-08 株式会社オステオファーマ 組換えヒト骨形成タンパク質－２凍結乾燥製剤
US9630916B2 (en) 2014-08-19 2017-04-25 Wisconsin Alumni Research Foundation Organocatalysts of oxidative protein folding
WO2017040363A1 (en) 2015-09-02 2017-03-09 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds
WO2021050009A2 (en) * 2019-09-13 2021-03-18 National Science And Technology Development Agency Composition of renaturation buffer solution for dimeric proteins and method of renaturation dimeric proteins using the composition thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
US5187076A (en) 1986-07-01 1993-02-16 Genetics Institute, Inc. DNA sequences encoding BMP-6 proteins
ZA874681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
US5106748A (en) 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
GB8927546D0 (en) 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
DE69132823T2 (de) 1990-05-16 2002-07-18 Genetics Institute, Inc. Knochen- und knorpel-bildung hervorrufende proteine
KR100255415B1 (ko) 1991-06-25 2000-05-01 브루스 엠. 에이센 비엠피-9 조성물
WO1993016099A2 (en) 1992-02-12 1993-08-19 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Dna sequences encoding novel growth/differentiation factors
DE4208568A1 (de) 1992-03-18 1993-09-23 Zimmer Ag Verfahren und vorrichtung zur herstellung synthetischer endlosfilamente
IL106278A0 (en) 1992-07-13 1993-11-15 Sumitomo Metal Ind Bone formation-inducing protein
EP1475440A3 (de) 1993-01-12 2004-11-17 The Johns Hopkins University School Of Medicine Wachstums-Differentierungsfaktor-3
CA2153653C (en) 1993-01-12 2010-12-07 Se-Jin Lee Growth differentiation factor-9
CA2153654A1 (en) 1993-01-12 1994-07-21 Se-Jin Lee Growth differentiation factor-5
CA2157577C (en) 1993-03-19 2009-11-17 Se-Jin Lee Growth differentiation factor-8
KR100231640B1 (ko) 1993-05-12 1999-12-01 토마스 제이 데스로저 Bmp-10 조성물
EP2272959A1 (de) 1993-05-12 2011-01-12 Genetics Institute, LLC BMP-11 Zusammenstellungen
CA2165776A1 (en) 1993-07-09 1995-01-19 Se-Jin Lee Growth differentiation factor-6
JPH09503904A (ja) 1993-07-09 1997-04-22 ザ ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン 増殖分化因子−７
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
EP0725796A4 (de) 1993-10-08 1999-12-01 Univ Johns Hopkins Wachstumsdifferenzierungsfaktor-10
WO1995016035A2 (en) 1993-12-07 1995-06-15 Genetics Institute, Inc. Bmp-12, bmp-13 and tendon-inducing compositions thereof
US5399677A (en) * 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
FR2714906B1 (fr) 1994-01-12 1996-02-02 Commissariat Energie Atomique Agents de solubilisation de biomolécules constitués par des zwitterions non détergents et leurs utilisations.
JPH07250688A (ja) 1994-01-28 1995-10-03 Sagami Chem Res Center ＴＧＦ−βスーパーファミリー蛋白質をコードするヒト新規ｃＤＮＡ
WO1996001845A1 (en) 1994-07-08 1996-01-25 The Johns Hopkins University School Of Medicine Growth differentiation factor-11
DE69518760T2 (de) 1994-07-13 2001-05-23 The Johns Hopkins University School Of Medicine, Baltimore Wachstumsdifferenzierungsfaktor-12
US5635372A (en) 1995-05-18 1997-06-03 Genetics Institute, Inc. BMP-15 compositions

Also Published As

Publication number Publication date
AU9116798A (en) 1999-04-27
JP2001519149A (ja) 2001-10-23
US6593107B1 (en) 2003-07-15
US6596511B1 (en) 2003-07-22
US20020052026A1 (en) 2002-05-02
EP1021528B1 (de) 2004-01-28
WO1999018196A1 (en) 1999-04-15
CA2305559A1 (en) 1999-04-15
AU757692B2 (en) 2003-03-06
EP1021528A1 (de) 2000-07-26
US6632635B1 (en) 2003-10-14
DE69821376D1 (de) 2004-03-04
US6593106B1 (en) 2003-07-15

Similar Documents

Publication Publication Date Title
ATE258598T1 (de) Verfahren zur proteinrückfaltung durch verwendung zwitterionischer wirkstoffe von niedrigem molekulargewicht
ATE449186T1 (de) Zusammensetzungen und verfahren zur selektiven nukleinsäureisolierung
BR9915679A (pt) Composições e métodos para aumentar a mineralização óssea
DE69825521D1 (de) Verfahren zur Herstellung von Silicon-in-Wasser-Emulsionen
DE50303749D1 (de) Verfahren zur herstellung von phthalocyaninpigmentzubereitungen
BR9509665A (pt) Composto composições e métodos
DE59809115D1 (de) Verfahren zur Herstellung von Polysiloxan-Polycarbonat-Blockcokondensaten
ATE408624T1 (de) Verfahren zur reinigung von fsh
DE60326012D1 (de) Verfahren zur Konzentration von Proteinen
EA199900643A1 (ru) Сульфамидные ингибиторы металлопротеаз
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
DE50001027D1 (de) Verfahren zur Herstellung von substituierten Olefinen
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
DE69822251D1 (de) Verfahren zur Herstellung von mikrobieller Transglutaminase
ATE220558T1 (de) Verbessertes verfahren zur stabilisierung von proteinen
ATE207205T1 (de) Verfahren zumm assay von endotoxin-konzentration
ATE506370T1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
DE69918605D1 (de) Verfahren zur Herstellung von Kaliumoxonat
WO1997008934A3 (en) Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
SE9602822D0 (sv) New receptor
AR022150A1 (es) Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados
DE69827268D1 (de) Verfahren und zusammensetzungen zur raschen aufreinigung von proteasomen und verfahren zur verwendung entsprechender komponenten
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
EA200000522A1 (ru) 5-htагонисты
DE59807115D1 (de) Verfahren zur Herstellung von Alkoxysilanen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties